Doctors have a big role in talking to patients about these risks
A significant milestone to bring in the new year, the FDA approved Wegovy (semaglutide) on Dec
[64], which involved a co-culture of primary astrocytes with the bEnd.3 endothelial cell line, incubation with exendin-4 reduced the levels of the astrocyte-derived vascular endothelial growth factor (VEGF-A), matrix metalloproteinase-9 (MMP-9), chemokine monocyte chemoattractant protein-1 (MCP-1), and the chemokine C-X-C motif ligand 1 (CXCL-1), induced by oxygenglucose deprivation (OGD), and subsequently led to the increased expression of tight junction proteins in the bEnd.3 cells
Nature 434 , 907913 (2005)
Many providers may have access to sample pens, allowing you to try the medication before committing to a prescription
Side effects drop significantly at lower doses, and costs can be one-quarter to one-third of standard therapy